Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Aug 14;98(17):9517-20.
doi: 10.1073/pnas.161239298.

Propagating conformational changes over long (and short) distances in proteins

Affiliations

Propagating conformational changes over long (and short) distances in proteins

E W Yu et al. Proc Natl Acad Sci U S A. .

Abstract

The problem of the propagation of conformational changes over long distances or through a closely packed protein is shown to fit a model of a ligand-induced conformational change between two protein states selected by evolution. Moreover, the kinetics of the pathway between these states is also selected so that the energy of ligand binding and the speed of the transition between conformational states are physiologically appropriate. The crystallographic data of a wild-type aspartate receptor that has negative cooperativity and a mutant that has no cooperativity but has native transmembrane signaling are shown to support this model.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) The backbone atoms in the α4 helix, shown at the left, compared with the backbone atoms of the α1 helix, shown at the right, for the wild-type protein. The red line is the apoprotein and the yellow line is the protein with aspartate bound. (b) The same comparison as a, but for the S68A receptor.
Figure 2
Figure 2
Side chains in the helices α1 and α4 that shift relative to each other on binding aspartate.
Figure 3
Figure 3
The alternative pathways for the ligand-induced change. The extremes represent pathways in which (i) the apoprotein isomerizes to conformation B (= formula image), which then binds substrate formula image (top); (ii) the ligand binds to the apoprotein conformation that then isomerizes to form the final bound-ligand conformation (formula imageformula imageformula image) (bottom); or (iii) the protein isomerizes to a conformation somewhere in between formula image and formula image and then binds to the ligand and reaches the final state (formula imageformula imageformula imageformula image) (middle). Glossary: A = formula image, the conformation of the protein in the absence of ligand. B = formula image, the conformation of the protein in the presence of ligand. C = formula image, an intermediate conformation containing elements of A and B. AS = formula image, BS = formula image, CS = formula image, the ligand bound to the protein in the A, B, and C conformations, respectively. Kobs = the observed affinity constant of the receptor = KtABKSB. KtAB = [B]/[A]. KtAC = [C]/[A]. KtCB = [B]/[C].
Figure 4
Figure 4
The energetics of the conformation changes when a ligand binds to a protein. Conformational states are shown as potential wells depicting the changing energetics of small displacement from the most stable conformation of that well. The conformation A is the most stable conformation of the apoprotein, but B exists at a higher energy state, its amount depending on the kinetics and KtAB. The presence of a ligand will stabilize conformation B but will destabilize the A conformation because S has very little attraction to the apo conformation.
Figure 5
Figure 5
Possible mechanisms for ligand-induced changes in the aspartate receptor. On the right is a wedge mechanism in which a ligand is attracted into a position between rigid side chains and deflects one helix downwards relative to the other. On the left is an attraction shift mechanism in which the binding of a ligand attracts hydrogen bonds, leading to a shifting of hydrogen bonds and causing the downward shift of helix α4 relative to helix α1.

References

    1. Otteman K M, Xiao W, Shin Y-K, Koshland D E., Jr Science. 1999;285:1751–1753. - PubMed
    1. Gerstein M, Lesk A M, Chothia G. Biochemistry. 1994;33:6739–6749. - PubMed
    1. Johnson L N, Noble M E M, Owen D J. Cell. 1996;85:149–158. - PubMed
    1. Perutz M F. Nature (London) 1970;228:726–739. - PubMed
    1. Nissen P, Hansen J, Ban N, Moore P B, Steitz T A. Science. 2000;289:920–930. - PubMed

Publication types

Associated data

LinkOut - more resources